Effects of phosphoinositide 3-kinase inhibitor SHBM1009 on cancer cells proliferation

Authors

  • Dujiao Wu Zhongshan Hospital Institute of Clinical Science, Fudan University , Shanghai 200032, China; Shanghai Institute of Clinical Bioinformatics,Shanghai 200032,China;
  • LiHao Huang Department of Pathology and Immunology,Washington University in St.Louis, School of Medicine
  • Qi Shen Zhongshan Hospital Institute of Clinical Science, Fudan University ,Shanghai 200032, China; Shanghai Institute of Clinical Bioinformatics,Shanghai 200032,China;
  • Bijun Zhu Zhongshan Hospital Institute of Clinical Science, Fudan University ,Shanghai 200032, China; Shanghai Institute of Clinical Bioinformatics,Shanghai 200032,China;

Keywords:

PI3K×cancer×cell proliferation×real-time cell monitoring×

Abstract

Phosphoinositide 3-kinase (PI3K) plays an important role in cellular proliferation and tumor progression. The objective of this study is to evaluate the potential mechanism and therapeutic effects of new PI3K inhibitor SHBM1009 on various cancer cells of digestive system on proliferation.

Downloads

Published

2023-03-27

How to Cite

Wu , D., Huang , L., Shen , Q., & Zhu , B. (2023). Effects of phosphoinositide 3-kinase inhibitor SHBM1009 on cancer cells proliferation. Molecular Cellular Therapy and Mechanism, 6(1), 15–22. Retrieved from https://journal.riverpublishers.com/index.php/MCTM/article/view/209

Issue

2018: Vol 6 Iss 1 2018

Section

Articles